Why the study?
Does itopride improve gastric emptying and gastrointestinal symptoms in type 1 diabetes mellitus patients with autonomic neuropathy?
Does itopride improve gastric emptying and gastrointestinal symptoms in type 1 diabetes mellitus patients with autonomic neuropathy?
Itopride therapy significantly reduces gastric emptying time in type 1 diabetes patients with autonomic neuropathy and delayed gastric emptying.
Supports itopride for gastroparesis in T1DM with autonomic neuropathy; extends RCT evidence for prokinetics.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Budennaya et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: